dealase

Biotech · Private company

BioNTech SE

Track this companyFree. Adds BioNTech SE to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs41From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials

Pipeline41

Clinical trials25

  • A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)PHASE2 · NOT_YET_RECRUITING · started Nov 30, 2026ClinicalTrials.gov NCT07871214 · fetched Nov 12, 2026
  • A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)PHASE1_PHASE2 · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07843940 · fetched Nov 12, 2026
  • A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIVPHASE1 · RECRUITING · started Aug 4, 2026ClinicalTrials.gov NCT07698600 · fetched Nov 12, 2026
  • A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerPHASE3 · RECRUITING · started Apr 22, 2026ClinicalTrials.gov NCT07365995 · fetched Nov 12, 2026
  • A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)PHASE1_PHASE2 · RECRUITING · started Mar 26, 2026ClinicalTrials.gov NCT07293351 · fetched Nov 12, 2026
  • A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)PHASE3 · RECRUITING · started Mar 16, 2026ClinicalTrials.gov NCT07361497 · fetched Nov 12, 2026
  • A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)PHASE1_PHASE2 · RECRUITING · started Mar 16, 2026ClinicalTrials.gov NCT07291076 · fetched Nov 12, 2026
  • A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)PHASE2_PHASE3 · RECRUITING · started Mar 13, 2026ClinicalTrials.gov NCT07221149 · fetched Nov 12, 2026
  • A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)PHASE3 · RECRUITING · started Mar 12, 2026ClinicalTrials.gov NCT07361510 · fetched Nov 12, 2026
  • A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal CancerPHASE2_PHASE3 · RECRUITING · started Dec 31, 2025ClinicalTrials.gov NCT07221357 · fetched Nov 12, 2026
  • A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9PHASE1_PHASE2 · RECRUITING · started Nov 18, 2025ClinicalTrials.gov NCT07186842 · fetched Nov 12, 2026
  • ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerPHASE3 · RECRUITING · started Oct 30, 2025ClinicalTrials.gov NCT07173751 · fetched Nov 12, 2026
  • A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)PHASE1_PHASE2 · RECRUITING · started Sep 22, 2025ClinicalTrials.gov NCT07111520 · fetched Nov 12, 2026
  • A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsPHASE1_PHASE2 · RECRUITING · started Aug 12, 2025ClinicalTrials.gov NCT07070232 · fetched Nov 12, 2026
  • DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsPHASE2 · RECRUITING · started Jul 18, 2025ClinicalTrials.gov NCT06953089 · fetched Nov 12, 2026
  • A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerPHASE3 · RECRUITING · started Jun 10, 2025ClinicalTrials.gov NCT06340568 · fetched Nov 12, 2026
  • A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerPHASE1_PHASE2 · RECRUITING · started Apr 23, 2025ClinicalTrials.gov NCT06827236 · fetched Nov 12, 2026
  • Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung CancerPHASE3 · RECRUITING · started Feb 3, 2025ClinicalTrials.gov NCT06712355 · fetched Nov 12, 2026
  • Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)PHASE2_PHASE3 · RECRUITING · started Jan 7, 2025ClinicalTrials.gov NCT06712316 · fetched Nov 12, 2026
  • A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 9, 2024ClinicalTrials.gov NCT06534983 · fetched Nov 12, 2026
  • Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With ChemotherapyPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 5, 2024ClinicalTrials.gov NCT06449209 · fetched Nov 12, 2026
  • A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Aug 17, 2023ClinicalTrials.gov NCT05914116 · fetched Nov 12, 2026
  • A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes LesionsPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 8, 2022ClinicalTrials.gov NCT05432583 · fetched Nov 12, 2026
  • A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 8, 2021ClinicalTrials.gov NCT04486378 · fetched Nov 12, 2026
  • A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Jan 7, 2021ClinicalTrials.gov NCT04534205 · fetched Nov 12, 2026